Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Karmanos Cancer Institute

Below is an extended Karmanos Cancer Institute research listing. Click here to return to the Karmanos Cancer Institute main Biocorporate entry.

Recent Publications by Karmanos Cancer Institute:

Dynamic contrast-enhanced magnetic resonance imaging of vascular changes induced by sunitinib in papillary renal cell carcinoma xenograft tumors.
To investigate further the antiangiogenic potential of sunitinib for renal...
11th November, 2009
Department of Radiation Oncology, Barbara Ann Karmanos Cancer Institute, Neoplasia. 2009 Sep;11(9):910-20.
Satraplatin: leading the new generation of oral platinum agents.
Background: In recent years, JM-216/satraplatin (GPC Biotech, Inc.) has...
6th November, 2009
Wayne State University, Barbara Ann Karmanos Cancer Institute, Department Expert Opin Investig Drugs. 2009 Nov;18(11):1787-97.
DOI Direct Link
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
Background: In recent years, JM-216/satraplatin (GPC Biotech, Inc.) has...
5th November, 2009
Karmanos Cancer Institute, Wayne State University, Detroit, Michigan J Thorac Oncol. 2009 Nov;4(11 Suppl 3):S1084-5.
DOI Direct Link
Novel 8-hydroxylquinoline analogs induce copper-dependent proteasome inhibition and cell death in human breast cancer cells.
An elevated level of copper (Cu), which is necessary for the growth and...
4th November, 2009
The Prevention Program, Barbara Ann Karmanos Cancer Institute, and Int J Oncol. 2009 Dec;35(6):1481-91.
Pancreatic cancer stem cells and EMT in drug resistance and metastasis.
Pancreatic cancer (PC) is an aggressive malignancy with one of the worst...
28th October, 2009
Department of Pathology, Barbara Ann Karmanos Cancer Institute, Wayne Minerva Chir. 2009 Oct;64(5):489-500.
Consensus Report of the National Cancer Institute Clinical Trials Planning Meeting on Pancreas Cancer Treatment.
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of...
28th October, 2009
Karmanos Cancer Institute, Wayne State University, Detroit, MI; National J Clin Oncol. 2009 Oct 26.
DOI Direct Link
Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
Malignant ascites may be the first presentation of an unsuspected cancer....
27th October, 2009
Department of Pathology, Wayne State University and Karmanos Cancer Diagn Cytopathol. 2009 Oct 23.
DOI Direct Link
Clinicopathological analysis of primary epithelial appendiceal neoplasms.
Appendiceal carcinomas are classified into three distinct...
24th October, 2009
Division of Hematology/Oncology, Karmanos Cancer Institute, Wayne State Med Oncol. 2009 Oct 23.
DOI Direct Link
The effect of uncertainty in exposure estimation on the exposure-response relation between 1,3-butadiene and leukemia.
In a follow-up study of mortality among North American synthetic rubber...
15th October, 2009
Wayne State University School of Medicine, Karmanos Cancer Institute, Int J Environ Res Public Health. 2009 Sep;6(9):2436-55. Epub 2009 Sep 11.
DOI Direct Link
Preclinical Studies of Apogossypolone, a Novel Pan Inhibitor of Bcl-2 and Mcl-1, Synergistically Potentiates Cytotoxic Effect of Gemcitabine in Pancreatic Cancer Cells.
OBJECTIVE:: Overexpression of antiapoptotic Bcl-2 family proteins confers...
14th October, 2009
From the *Divisions of Pathology, and daggerHematology and Oncology, Pancreas. 2009 Oct 8.
DOI Direct Link
Cryotherapy for breast cancer: a feasibility study without excision.
PURPOSE: To assess the feasibility of percutaneous multiprobe breast...
6th October, 2009
Department of Radiology, Karmanos Cancer Institute, 721 Harper Prof. Bldg J Vasc Interv Radiol. 2009 Oct;20(10):1329-41.
DOI Direct Link
l-Valine ester of cyclopropavir: a new antiviral prodrug.
BACKGROUND: Following the example of l-valine prodrugs of antiviral...
2nd October, 2009
Barbara Ann Karmanos Cancer Institute, Wayne State University School of Antivir Chem Chemother. 2009 Sep 25;20(1):37-46.
DOI Direct Link
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.
Earlier, mapping of the 9p23-24 amplicon in esophageal cancer cell lines...
29th September, 2009
Department of Pathology, Breast Cancer Program, Karmanos Cancer Institute, Oncogene. 2009 Sep 28.
DOI Direct Link
Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells.
Although cisplatin is a very effective anticancer agent against several...
17th September, 2009
Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Cell Cycle. 2009 Oct 1;8(19):3191-8. Epub 2009 Oct 7.
Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.
In situ expression of a foreign antigen and an immune-modulating cytokine...
5th September, 2009
Karmanos Cancer Institute, Wayne State University, 110 E. Warren Ave., Cancer Immunol Immunother. 2009 Sep 3.
DOI Direct Link

«Karmanos Cancer Institute

This page contained an extended Karmanos Cancer Institute research listing. Click here to return to the Karmanos Cancer Institute main Biocorporate entry.


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.